FindTrial
Sign In

A study to explore patient survival in N2 patients with non-small cell lung cancer who received surgeries plus adjuvant therapies and surgeries plus perioperative chemotherapies

A multi-centre real-world non-interventional observational study to compare effectiveness and safety of surgeries + adjuvant chemotherapies and surgeries + perioperative adjuvant chemotherapies in N2 patients with non-small cell lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014702
Enrollment
Unknown
Registered
2018-01-30
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Case series:Surgeries+adjuvant chemotherapies

Sponsors

Tangdu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patients who were enrolled in clinics from 2014 to 2017 and met all the following criteria will be included in the study: 1. Patients with radical resection of lung cancer; 2. Pathologically diagnosed patients with non-small cell lung cancer; 3. Patients with age > 18 years; 4. Patients who were not performed with chest surgeries; 5. Patients with N2 lymph modes(+); 6. Patients who received lymphadenectomy with one or more than one group of lymph nodes.

Exclusion criteria

Exclusion criteria: Patients with second primary tumors or multiple primary lung cancer

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Disease-free survival;—

Countries

China

Contacts

Public ContactXiaofei Li

Tangdu Hospital

lxfchest@fmmu.edu.cn+86 15009266699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026